Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.

Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, Fiore MC, Stein JH.

J Am Coll Cardiol. 2010 May 4;55(18):1988-95. doi: 10.1016/j.jacc.2010.03.002. Epub 2010 Mar 17.

2.
3.

Effects of vitamin E on chronic and acute endothelial dysfunction in smokers.

Neunteufl T, Priglinger U, Heher S, Zehetgruber M, Söregi G, Lehr S, Huber K, Maurer G, Weidinger F, Kostner K.

J Am Coll Cardiol. 2000 Feb;35(2):277-83.

4.

Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial.

Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH.

Am Heart J. 2011 Jan;161(1):145-51. doi: 10.1016/j.ahj.2010.09.023.

5.

Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.

Hausberg M, Kosch M, Stam F, Heidenreich S, Kisters K, Rahn KH, Barenbrock M.

Kidney Int. 2001 Apr;59(4):1473-9.

PMID:
11260410
6.

γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation.

Mah E, Pei R, Guo Y, Ballard KD, Barker T, Rogers VE, Parker BA, Taylor AW, Traber MG, Volek JS, Bruno RS.

Free Radic Biol Med. 2013 Dec;65:1291-9. doi: 10.1016/j.freeradbiomed.2013.09.016. Epub 2013 Sep 27.

PMID:
24075893
7.

Atorvastatin normalizes endothelial function in healthy smokers.

Agewall S, Hernberg A.

Clin Sci (Lond). 2006 Jul;111(1):87-91.

PMID:
16608440
8.

Impaired brachial artery endothelial function is not predicted by elevated triglycerides.

Schnell GB, Robertson A, Houston D, Malley L, Anderson TJ.

J Am Coll Cardiol. 1999 Jun;33(7):2038-43.

9.

What is the most appropriate methodology for detection of conduit artery endothelial dysfunction?

Guthikonda S, Sinkey CA, Haynes WG.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1172-6. Epub 2007 Feb 15.

10.

Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease.

Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI.

Am J Cardiol. 1999 Mar 1;83(5):754-8.

PMID:
10080432
11.

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.

Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, Creager MA.

Circ Res. 2004 Jul 23;95(2):217-23. Epub 2004 Jun 3.

12.

Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.

Lee SJ, Lee DW, Kim KS, Lee IK.

Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S81-92.

PMID:
11733113
13.

[The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].

Chen H, Ren JY, Wu B, Liu X, Wang RJ, Li LJ, Luo Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Jun;35(6):531-5. Chinese.

PMID:
17711713
14.

Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men.

Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR.

J Am Coll Cardiol. 2001 Nov 1;38(5):1313-9.

15.

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.

Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF, Davies JS.

Clin Endocrinol (Oxf). 2002 Apr;56(4):493-501.

PMID:
11966742
16.

Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers.

Siasos G, Tousoulis D, Kokkou E, Oikonomou E, Kollia ME, Verveniotis A, Gouliopoulos N, Zisimos K, Plastiras A, Maniatis K, Stefanadis C.

Am J Hypertens. 2014 Jan;27(1):38-45. doi: 10.1093/ajh/hpt176. Epub 2013 Sep 23.

PMID:
24061071
17.

Effects of smoking regular or light cigarettes on brachial artery flow-mediated dilation.

Amato M, Frigerio B, Castelnuovo S, Ravani A, Sansaro D, Tremoli E, Squellerio I, Cavalca V, Veglia F, Sirtori CR, Werba JP, Baldassarre D.

Atherosclerosis. 2013 May;228(1):153-60. doi: 10.1016/j.atherosclerosis.2013.02.037. Epub 2013 Mar 13.

PMID:
23528831
18.

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.

Lüscher TF, Taddei S, Kaski JC, Jukema JW, Kallend D, Münzel T, Kastelein JJ, Deanfield JE; dal-VESSEL Investigators.

Eur Heart J. 2012 Apr;33(7):857-65. doi: 10.1093/eurheartj/ehs019. Epub 2012 Feb 16.

19.

Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.

Warnholtz A, Wild P, Ostad MA, Elsner V, Stieber F, Schinzel R, Walter U, Peetz D, Lackner K, Blankenberg S, Munzel T.

Atherosclerosis. 2009 May;204(1):216-21. doi: 10.1016/j.atherosclerosis.2008.08.003. Epub 2008 Aug 12.

PMID:
18822413
20.

Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.

Jambrik Z, Venneri L, Varga A, Rigo F, Borges A, Picano E.

Am Heart J. 2004 Oct;148(4):684-9.

PMID:
15459601
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk